Incidencia de reacciones adversas a la inmunoterapia en pacientes alérgicos del Hospital Universitario de Puebla

Revista Alergia Mexico

Volumn 45, Issue 6, 1998, Pages 147-149

  Jiménez, Graciela Sosa ^a,b   García, Aida López ^a   García, José Arturo Galindo ^a   Martínez, David Paz ^a   Tamez, Roberto Carrillo ^a   Tapia, Sergio Papaqui ^a  

^a Servicio de Anestesiología del Hospital General de Cholula   (Mexico)

^b Unidad Habitational San Bartolo   (Mexico)

Author keywords

Adverse reaction incidence; Immunotherapy

Indexed keywords

ANTIGEN; IMMUNOMODULATING AGENT;

ADULT; ALLERGY; ARTICLE; ASTHMA; CONCENTRATION RESPONSE; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEXICO; PATHOGENESIS; RHINITIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032465667     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Huerta LJ. Inmunoterapia: una terapéutica moderna con historia. Alerg Pediatr 1993;2:4-5.
2. pérez MJ. Inmunologia en el ano 2000: historia y futuro. Rev Alerg Méx 1994; 42: 1-3.
3. Tinkelman DG, Cole WQ, Tunno J. Immunotherapy: a one year prospective systemic reactions. J Allergy Clin Immunol 1995; 95:8-14.
4. Bukantz SC, Richard F, Lockey MD. Adverse effects and fatalities associated with immunotherapy and skin testing. Am Acad Allergy Immunol 1994; 8:1-6.
5. Van Metre TE, Adkinson FN. Inmunoterapia para la enfermedad por aeroalergenos. En: Middleton E, Reed E, Ellis FE, Adkinson FN. Yunginger WJ, editores. Alergia: principios y práctica. Barcelona: Salvat Editores, 1992; 2:1231-47.
6. Fisher M. Treatment of anaphylaxie. Br Med J 1995; 87:265-268
7. Lin M S, Tanner E F. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 1993; 71:557-62.
8. Tabar A, García B, Rodriguez A. A prospective safety-monitoring study of immunotherapy with biologically standardized extracts. Allergy 1993; 48:450453
9. Cook P, Bryant J, Davis W. Systemic reactions to immunotherapy. Am Acad Otolaryn Allergy 1994; 110:487-93.
10. Bousquet J, Michel F. Safety considerations in assessing the role of immunotherapy in allergy disorders. Drug 1994; 10:5-7.
11. Matioff SM, Bsilit W, Parks P. Systemic reactions to immunotherapy. Allergy 1993; 14:347-50.
12. Lawrence M, Du Buske, Carolyn J, Ling M D. Special problems regarding allergen immunotherapy. Allergy 1992; 12:145-70.
13. Norma PS, Metre TE. The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990; 85:522-24.
14. Reid MJ, Lockey RF, Tukeitaub PC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1990; 85:180-3.
15. Teinberg P, Milles J, Anderson D. Reflux sympathetic distrophy: and adverse reaction to immunotherapy. J Allergy Clin Immunol 1995; 3:775-6.
16. Muñoz V, López L, Pedroza A, Huerta IJ. Reacciones adversas en 100 niños con inmunoterapia supervisada: un año de seguimiento. Aler Pediatr 1994;3:4546.